Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers.
Pillai O, Nair V, Panchagnula R. Pillai O, et al. Among authors: panchagnula r. Int J Pharm. 2004 Jan 9;269(1):109-20. doi: 10.1016/j.ijpharm.2003.09.032. Int J Pharm. 2004. PMID: 14698582
Statistical evaluation of physiological variability of rifampicin in fixed dose combinations.
Panchagnula R, Parmar J, Kaur K, Singh I, Bade SR, Ashokraj Y. Panchagnula R, et al. Int J Pharm. 2006 Apr 26;313(1-2):5-13. doi: 10.1016/j.ijpharm.2005.12.049. Epub 2006 Mar 6. Int J Pharm. 2006. PMID: 16517107
Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride.
Panchagnula R, Dravid P, Jain A, Khandavilli S. Panchagnula R, et al. Arzneimittelforschung. 2005;55(4):198-204. doi: 10.1055/s-0031-1296845. Arzneimittelforschung. 2005. PMID: 15901042
Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Panchagnula R, et al. Int J Pharm. 2005 Apr 11;293(1-2):213-23. doi: 10.1016/j.ijpharm.2005.01.004. Int J Pharm. 2005. PMID: 15778059
pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV, Panchagnula R. Varma MV, et al. Among authors: panchagnula r. J Pharm Sci. 2005 Dec;94(12):2632-43. doi: 10.1002/jps.20489. J Pharm Sci. 2005. PMID: 16258992
In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P, Varma MV, Chawla HP, Panchagnula R. Sharma P, et al. Among authors: panchagnula r. Farmaco. 2005 Nov-Dec;60(11-12):874-83. doi: 10.1016/j.farmac.2005.08.007. Epub 2005 Oct 21. Farmaco. 2005. PMID: 16243320
Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P, Varma MV, Chawla HP, Panchagnula R. Sharma P, et al. Among authors: panchagnula r. Farmaco. 2005 Nov-Dec;60(11-12):884-93. doi: 10.1016/j.farmac.2005.08.008. Epub 2005 Oct 13. Farmaco. 2005. PMID: 16226752
Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers.
Sharma P, Varma MV, Chawla HP, Panchagnula R. Sharma P, et al. Among authors: panchagnula r. Farmaco. 2005 Nov-Dec;60(11-12):870-3. doi: 10.1016/j.farmac.2005.08.006. Epub 2005 Sep 21. Farmaco. 2005. PMID: 16182296
Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R, Desu H, Jain A, Khandavilli S. Panchagnula R, et al. Farmaco. 2005 Nov-Dec;60(11-12):894-9. doi: 10.1016/j.farmac.2005.07.004. Epub 2005 Aug 26. Farmaco. 2005. PMID: 16126203
Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV, Panchagnula R. Varma MV, et al. Among authors: panchagnula r. J Pharm Sci. 2005 Aug;94(8):1694-704. doi: 10.1002/jps.20309. J Pharm Sci. 2005. PMID: 15986467
A significant correlation was obtained between rat ileum permeability and the literature human intestinal absorption (HIA), F(a,human) (r = 0.891; p < 0.01). ...
A significant correlation was obtained between rat ileum permeability and the literature human intestinal absorption (HIA), F(a,human) (r
120 results
Jump to page
Feedback